Takeda Pharmaceutical Purchases URL Pharma
Announced April 11, a Ropes & Gray team led by Boston-based securities & public companies partners Marko Zatylny
and Paul Kinsella
with associates Zachary Blume
and Reagan Bissonnette
represented URL Pharma in its $800 million cash sale to Takeda Pharmaceutical Co. Ltd, Japan's largest drugmaker.
URL is headquartered in Philadelphia, and its lead product is Colcrys, which is used to treat gout flare-ups. The deal is expected to close in early June.